Years of Life Lost Due to Cervical Cancer in Poland in 2000 to 2015

Pikala, Małgorzata; Burzyńska, Monika; Maniecka-Bryła, Irena

doi:10.3390/ijerph16091545

Cited by 11 publications

(15 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…RR in the group of women with elementary education vs. university education was 1.7 in 2016. In contrast, for cervical cancer, RR was 5.8 [11]. This confirms the observation, noted in other studies conducted both in Poland [32] and in 22 European countries [33], that breast cancer is the most egalitarian of all cancers.…”

Section: Discussionsupporting

confidence: 88%

See 1 more Smart Citation

Trends of mortality due to breast cancer in Poland, 2000–2016

2020

Self Cite

View full text Add to dashboard Cite

Background: The aim of the study was to assess trends in mortality and the number of lost years of life due to breast cancer in the female population in the years 2000-2016, with consideration given to differences regarding the level of education and place of residence. Methods: The analysis was based on a database of the Central Statistical Office of Poland, containing information gathered from 92,154 death certificates of all Polish female inhabitants who died in the period 2000-2016 due to breast cancer. The SEYLL p (Standard Expected Years of Life Lost per living person), the SEYLL d (per deaths), the APC (Annual Percentage Change), the AAPC (Average Annual Percentage Change) were calculated to determine years of life lost. Results: The mean age of women who died from breast cancer increased in the study period from 64.7 years to 69.7. The SEYLL p index (per 100,000) increased to 776.8 years in 2016 (AAPC = 0.5%). The most unfavorable changes were observed in the group of women with secondary education. In 2004, the SEYLL p values started to grow at a rate of 2.3% and since 2011, they have been higher than amongst women with elementary education. In the years 2000-2016, the authors observed that SEYLL p was steadily declining (APC =-1.0%) in the group of inhabitants of rural areas, whereas with regards to city dwellers, the SEYLL p index has been increasing since 2004 (APC = 0.5%), which has resulted in increased disproportions regarding the place of residence. Conclusions: The results of this study showed that breast cancer is becoming a serious epidemiological problem in Poland. There is the need to intensify activities among women at highest risk group and it should be the starting point for making key decision in combating breast cancer.

show abstract

Section: Discussionsupporting

confidence: 88%

“…The authors of this manuscript have used this method in their other studies on lost years of life due to cancers. Further details on the SEYLL index are available in the authors' earlier publications [11,12].…”

Section: Methodsmentioning

confidence: 99%

Trends of mortality due to breast cancer in Poland, 2000–2016

2020

Self Cite

View full text Add to dashboard Cite

show abstract

“…CDC (Centers for Disease Control and Prevention) data show that in the United States, approximately 14 million people are infected with HPV every year, 12,000 women a year suffer from cervical cancer and 4,000 die of it. Poland is among the countries with the highest incidence rates in Europe (over 3,000 cases per year) and cervical cancer mortality (7.9 cases per 100,000 women) [11].…”

Section: Wprowadzeniementioning

confidence: 99%

“…Dane amerykańskich Centrów Kontroli i Prewencji Chorób (Centers for Disease Control and Prevention -CDC) wskazują, że w Stanach Zjednoczonych co roku zakażeniu HPV ulega ok. 14 milionów osób, u 12 000 kobiet występuje rak szyjki macicy, a 4000 umiera z tego powodu. Polska jest jednym z krajów o najwyższych wskaźnikach zachorowalności (ponad 3000 przypadków rocznie) i śmiertelności (7,9 na 100 000 kobiet) z powodu raka szyjki macicy w Europie [11].…”

Section: Wprowadzenieunclassified

Human papillomavirus (HPV) coinfection with other sexually transmitted infections in patients of the Department of Dermatology and Venereology at the Medical University of Warsaw

Bukowska¹,

Młynarczyk-Bonikowska²,

Malejczyk³

et al. 2020

View full text Add to dashboard Cite

Introduction. Infections with the genital types of human papillomavirus (HPV) are usually eliminated by the immune system within 6-18 months. Other concurrent sexually transmitted infections may be one of the factors contributing to the infection and its longer persistence. Objective. To assess the prevalence of HPV and coinfections with other sexually transmitted infections. Material and methods. Forty women with at least one sexually transmitted infection and 45 women from the control group were examined. For gonorrhea and chlamydial infection diagnostics, culture and direct immunofluorescence were applied, respectively. In parallel, both infections were diagnosed using real-time PCR. Syphilis was diagnosed using serological tests VDRL and FTA-ABS tests, and HIV infection with enzymatic immunoassay. Real-time PCR was used to detect HPV6, 11, 16 and 18. Results. HPV infection was found in 60% of women in the study group and 42.22% in the control group. HPV16 infection was diagnosed in 58.3% of women infected with C. trachomatis, 57.9% with gonorrhea, 16.7% with syphilis and 26.7% of women in the control group. The percentage of those infected with two types of HPV in the study group was 22.5%, and 13.33% in the control group. A relationship was found between HPV16 infection and gonorrhea and chlamydial infection and between gonorrhea and infection with two different types of HPV. Conclusions. The obtained results indicate the influence of C. trachomatis and N. gonorrhoeae infections on the persistence of oncogenic HPV infections, which may lead to an increased risk of developing pre-cancerous lesions.

show abstract

“…In the study, apart from crude death rates (CDR) and standardised death rates (SDR), the standard expected years of life lost (SEYLL) index was also used. Measures expressing premature mortality in units of lost years of life are more and more frequently used to assess the health status of the population in international epidemiological literature [11,12,13,14,15,16].…”

Section: Introductionmentioning

confidence: 99%

Epidemiology of Mortality Due to Prostate Cancer in Poland, 2000–2015

Pikala

Burzyńska

Maniecka-Bryła

2019

IJERPH

Self Cite

View full text Add to dashboard Cite

The aim of the study was to assess trends in mortality and years of life lost due to prostate cancer (PCa) in Poland in 2000–2015. The crude death rates (CDR), standardised death rates (SDR), standard expected years of life lost per living person (SEYLLp) and per death (SEYLLd) values were calculated. Joinpoint models were used to analyse time trends. In the study period, 61,928 men died of PCa. The values of mortality rates in 2000 (per 100,000) were: CDR = 16.97, SDR = 16.17, SEYLLp = 332.1. In 2015, the values of all rates increased: CDR = 26.22, SDR = 16.69, SEYLLp = 429.5. However, the SEYLLd value decreased from 15.62 to one man who died due to PCa in 2000 to 13.78 in 2015. The highest SEYLLp values occurred in the group of men with primary education (619.5 in 2000 and 700.7 in 2015). They were respectively 2.24 and 2.96 times higher than in men with higher education (275.7 and 237.1). SEYLLp values increased in urban areas (from 295.7 to 449.4), slightly changed in the rural areas (from 391.5 to 400.2). Unfavorable trends in mortality due to PCa in Poland require explanation of the causes and implementation of appropriate actions aimed at mortality reducing.

show abstract

Years of Life Lost Due to Cervical Cancer in Poland in 2000 to 2015

Cited by 11 publications

References 30 publications

Trends of mortality due to breast cancer in Poland, 2000–2016

Trends of mortality due to breast cancer in Poland, 2000–2016

Human papillomavirus (HPV) coinfection with other sexually transmitted infections in patients of the Department of Dermatology and Venereology at the Medical University of Warsaw

Epidemiology of Mortality Due to Prostate Cancer in Poland, 2000–2015

Contact Info

Product

Resources

About